Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nektar Therapeutics (NKTR)

43.03   0.22 (0.51%) 02-20 16:00
Open: 43.09 Pre. Close: 42.81
High: 44.06 Low: 42.78
Volume: 1,290,015 Market Cap: 7448M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 44.117 - 44.296 44.296 - 44.465
Low: 42.339 - 42.536 42.536 - 42.723
Close: 42.719 - 43.024 43.024 - 43.314

Technical analysis

as of: 2019-02-20 4:45:14 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 51.87     One year: 55.02
Support: Support1: 40.04    Support2: 33.31
Resistance: Resistance1: 44.41    Resistance2: 47.11
Pivot: 43.20
Moving Average: MA(5): 42.48     MA(20): 43.23
MA(100): 41.49     MA(250): 60.35
MACD: MACD(12,26): 0.60     Signal(9): 0.97
Stochastic oscillator: %K(14,3): 34.94     %D(3): 27.63
RSI: RSI(14): 52.66
52-week: High: 111.36  Low: 29.22  Change(%): -50.2
Average Vol(K): 3-Month: 199296  10-Days: 178210

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NKTR has closed above bottom band by 46.5%. Bollinger Bands are 54.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to NKTR's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-02-18T13:49:00-05:00
Robbins Arroyo LLP: Nektar Therapeutics (NKTR) Officials Harmed the Company According to Shareholder Lawsuit

2019-02-18T12:02:28-05:00
Healthcare And Biotechnology Dashboard - Update

2019-02-18T07:45:00-05:00
Meridian Contrarian Fund Q4 2018 Commentary

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 173.09
Shares Float (M) 170.06
% Held by Insiders
% Held by Institutions 161.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 4.030
EPS Est. Current Year -0.980
EPS Est. Next Year -1.100
EPS Est. Next Quarter -0.350
Forward EPS -1.260
Book Value (p.s.) 4.090
PEG Ratio -1.51
Profit Margin 67.58
Operating Margin 62.84
Return on Assets (ttm) 52.8
Return on Equity (ttm) 79.6
Qtrly Rev. Growth -81.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 755.36
Levered Free Cash Flow (M) 505.72

Stock Valuations

P/E 10.68
P/E Growth Ratio 0.01
P/BV 10.52
P/S 989061376.00
P/CF 9.86

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.